TAS::75 0886::TAS MEDICINAL CHEMISTRY FOR NEUROTHERAPEUTICS PROGRAM (MCNP)

Information

  • Research Project
  • 8654918
  • ApplicationId
    8654918
  • Core Project Number
    N01NS000000
  • Full Project Number
    271201100013C-9-0-1
  • Serial Number
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/26/2013 - 11 years ago
  • Project End Date
    -
  • Program Officer Name
  • Budget Start Date
    -
  • Budget End Date
    -
  • Fiscal Year
    2013
  • Support Year
  • Suffix
  • Award Notice Date
    -

TAS::75 0886::TAS MEDICINAL CHEMISTRY FOR NEUROTHERAPEUTICS PROGRAM (MCNP)

The NIH is developing a Medicinal Chemistry for Neurotherapeutics Program (MCNP) to generate new optimized drugs leads for nervous system disorders. High-throughput screens and basic research studies have led to the discovery of many small molecule compounds with activity in models of nervous system disorders. Some of these compounds have the potential to be transformed into drugs for human use, with chemical modifications to improve their potency and pharmacological properties. The MCNP will support collaborations between a contracted medicinal chemistry facility and researchers (Contributors) with bioactive small molecule compounds and bioactivity assays to develop optimized drug leads.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    N01
  • Administering IC
    NS
  • Application Type
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    4471578
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
    NEI:2242000\NINDS:2229578\
  • Funding Mechanism
    Non SBIR/STTR Contracts
  • Study Section
  • Study Section Name
  • Organization Name
    ALBANY MOLECULAR RESEARCH, INC.
  • Organization Department
  • Organization DUNS
    787793900
  • Organization City
    ALBANY
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    122035121
  • Organization District
    UNITED STATES